A Stakeholder Analysis of Schistosomiasis Diagnostic Landscape in South-West Nigeria

Insights for Diagnostics Co-creation

Bibliographic Data

ID22069835
AuthorsAdeola Onasanya (0000-0001-9599-4316, Delft University of Technology, corresponding author), Maryam Keshinro (Leiden University Medical Center), Oladimeji Oladepo (0000-0002-2475-5729, University of Ibadan), Jo van Engelen (Delft University of Technology), Jan Carel Diehl (0000-0002-4007-2282, Delft University of Technology)
Year2020
Volume8
Pages564381-564381
Publication date2020-10-30
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2020.564381
PMID33194966
OpenAlexW3097674800
LanguageEN
References cited41

Background: Schistosomiasis, one of the neglected tropical diseases, is a water-based parasitic disease of public health importance. Currently, tests for Schistosoma haematobium infection either demonstrate poor specificity, are expensive or too laborious for use in endemic countries, creating a need for more sensitive, cheaper, and easy to use devices for the diagnosis of schistosomiasis. To ensure engagement during the process of device development; and effective acceptance and use after the introduction of diagnostics devices for S. haematobium, there is a need to involve stakeholders with varying power, interest, and stakes in device co-creation, as well as those relevant for later use situation in the diagnostic landscape. The main goal of this study is to identify and analyze relevant stakeholders for co-creation using a power-interest matrix. Materials and Methods: The study was based on an action research methodology using a case study approach. A contextual inquiry approach consisting of 2 stages: stakeholder identification and interview; and stakeholder analysis was used. The field part of the study was carried out in Oyo State, Nigeria using a multistage cluster purposive sampling technique based on the category of stakeholders to be interviewed predicated on the organizational structure within the state and communities. A mix of qualitative research techniques was used. Identified themes related to power and interest were mapped and analyzed. Results: We identified 17 characteristics of stakeholders across 7 categories of stakeholders important for schistosomiasis diagnostics. Most of the stakeholders were important for both the co-creation and adoption phase of the device development for diagnostics. However, not all stakeholders were relevant to co-creation. Key Stakeholders relevant for diagnostics co-creation demonstrated significant social power, organization power, and legitimate power bases. Most of the stakeholders showed significant interest in the device to be created. Discussion: The power and interest of these stakeholders reveal some insight into how each stakeholder may be engaged for both co-creation and device usage. The involvement of relevant actors who will also be important for co-creation and implementation, will simplify the engagement process for the critical stakeholders, increase the ability to manage the process, and increase diagnostic device acceptability

Business · Economics · Environmental health · Environmental resource management · Knowledge management · Neglected tropical diseases · Nonprobability sampling · Political science · Population · Process management · Public health · Public relations · Schistosomiasis · Stakeholder · Stakeholder analysis · Community Development and Social Impact · Computer Science · Innovation and Socioeconomic Development · Medicine · Nursing · Parasites and Host Interactions

Tools

Open DOIOpen Access